תפריט כתבה
‘Wild West’ peptide craze surges beyond GLP-1s as FDA faces pressure to ease access
FOX NEWS
14:00, עידכון: 14:21
The peptide market is surging alongside GLP-1 demand, creating tension between compounding pharmacies and commercial drug companies over patient access.
